Syndax Pharmaceuticals (SNDX) Non Operating Interest Expenses (2020 - 2026)
Syndax Pharmaceuticals' Non Operating Interest Expenses came in at $2,000 for Q3 2026, unchanged from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Syndax Pharmaceuticals reported Non Operating Interest Expenses of $4,000; for FY2025, it was $6,000.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of -69.7% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was -$1,000 in FY2024, $208,000 in FY2023 (-93.4%), $3.14 million in FY2022 (+65.2%) and $1.9 million in FY2021 (-19.4%).
- The five-year range for quarterly Non Operating Interest Expenses is -$124,000 (Q4 2024) to $1.75 million (Q3 2022).
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2022 (growth of 169.3%), and the weakest in Q1 2025 (a decline of 96.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Syndax Pharmaceuticals | 854.00 Mn | -867.10 Mn | 69.30 Mn | 2,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2,000.00 |
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 695,000.00 |
| Mar 31, 2022 | 651,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Jun 30, 2021 | 634,000.00 |
| Mar 31, 2021 | 623,000.00 |
API Access
Syndax Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();